Circulating Chymase and Chronic Kidney Disease: An Analysis of Current Treatments, Demographics, and Clinical Risk Factors
JSHS · 2024
Overview
Chronic kidney disease (CKD) results in a progressive loss of kidney function over time, affecting 37 million in the US. Chymase is the primary enzyme mediating angiotensin II formation independent of the angiotensin-converting enzyme, potentially causing renal fibrosis. This novel study investigated differences in chymase levels between CKD -affected populations and non -CKD-affected populations while adjusting for potential confounding of current treatment, clinical risk factors, and medical history. Popul ation was organized into two groups in New Orleans: participants diagnosed with CKD (n=163) and the control group, participants not diagnosed with CKD (n=186). Three models were created to measure differences in median chymase levels between the two groups while adjusting for common CKD risk factors and treatments. Medians and interquartile ranges for plasma chymase were calculated for both groups, and Mann-Whitney Utests determined differences in the unadjusted medians. Quantile regression was used to create the three models and obtain multivariable-adjusted medians for plasma chymase levels in both groups. Wald tests assessed differences in adjusted medians between the two groups for all three models. After adjustment for all variables tested, median plas ma chymase remained significantly higher (p=0.04) in CKD patients (1.7 pg/mL) compared to controls (1.2 pg/mL). This study established an association between elevated chymase levels and CKD, independent of all factors studied. Results provide the foundation for vital further research determining if chymase is a viable measure to predict CKD progression and assessing effectiveness of chymase inhibitors in improving renal outcomes for CKD patients.
Competition history
- JSHS 2024
Resources
Related projects
ISEF · 2024
Circulating Chymase and Chronic Kidney Disease: A Multivariable Analysis of Current Treatments, Demographics, and Clinical Risk Factors
ISEF · 2022
Assessment of Knowledge About Chronic Kidney Disease in the Panamanian Population
ISEF · 2021
Comparing Outcomes of COVID-19 Positive Individuals with and without Chronic Kidney Disease using Python and CoRDaCo
ISEF · 2016
Bioengineering Functional Kidney Tissue from Human Pluripotent Stem Cells: A Promising New Treatment for Kidney Disease
ISEF · 2019
The Potential Pathophysiological Role of STING in the Development of Hypertensive Nephropathy
ISEF · 2020
The Potential Pathophysiological Role of STING in the Development of Hypertensive and Diabetic Nephropathy
ISEF · 2022
Microneedles for Creatinine Detection: Novel Prototype of Non-Invasive Portable Tool Towards Chronic Kidney Disease Risk Assessment
JSHS · 2025
Interactions of Kidney Function Related Genes and Proteins with Anticancer Drugs and Strategies to Mitigate their Adverse Effects
Closest projects by meaning, across every fair and year in the corpus.